Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-021700·FORWARD VENTURES V LP
Schedule 13G ownership disclosure
VIRACTA THERAPEUTICS INC
Common Stock · CUSIP: 92765F108
Event date: 2024-12-31
- Filing-level shares
- 847,600
- Percent of class
- 4.3%
- Forward Ventures V, LP
Shares: 847,600 · Class: 4.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021700
- Form type
- SCHEDULE 13G
- Filer
- FORWARD VENTURES V LP
- CIK
- CIK 1232643
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership